From: Factors influencing completion of multi-dose vaccine schedules in adolescents: a systematic review
Recommended vaccines for all adolescents | Adolescent dosage | Licensed age |
 Tetanus, diphtheria, pertussis | 3 doses Tdapa & Td Booster | Infant onwards |
 Human papillomavirus | 2 doses if ≤15 years | ≥9 years |
3 doses thereafter | ||
 Meningococcal conjugate | MenA: 1 dose | Infant onwards |
MenC: 1 dose | ||
MCV4: 1 dose | ||
 Influenza | 1 dose Yearly booster | ≥9 years |
 Hepatitis A | 1 dose | Infant onwards |
 Hepatitis B | 3 dosesa | Infant onwards |
 Measles, Mumps, Rubella | 1 dosea | Infant onwards |
Recommended in at-risk areas | Adolescent dosage | Licensed age |
 Tick borne encephalitis | 3 doses | Infant onwards |
 Japanese encephalitis | 1 dose | Infant onwards |
 Typhoid | Vi polysaccharide: 1 dose | Infant onwards |
Ty21a live oral vaccine: 3–4 doses | ||
Booster 3–7 years after primary series | ||
 Cholera | Dukoral, Shanchol & mORCVAX: 2 doses booster every 2nd yr | ≥2 years |
 Rabies | 3 doses | Infant onwards |
 Varicella | 2 doses | ≥9–12 months |